287 related articles for article (PubMed ID: 20697118)
1. Visually isoattenuating pancreatic adenocarcinoma at dynamic-enhanced CT: frequency, clinical and pathologic characteristics, and diagnosis at imaging examinations.
Kim JH; Park SH; Yu ES; Kim MH; Kim J; Byun JH; Lee SS; Hwang HJ; Hwang JY; Lee SS; Lee MG
Radiology; 2010 Oct; 257(1):87-96. PubMed ID: 20697118
[TBL] [Abstract][Full Text] [Related]
2. The isoattenuating pancreatic adenocarcinoma: Review of the literature and critical analysis.
Blouhos K; Boulas KA; Tsalis K; Hatzigeorgiadis A
Surg Oncol; 2015 Dec; 24(4):322-8. PubMed ID: 26690821
[TBL] [Abstract][Full Text] [Related]
3. Small (≤ 20 mm) pancreatic adenocarcinomas: analysis of enhancement patterns and secondary signs with multiphasic multidetector CT.
Yoon SH; Lee JM; Cho JY; Lee KB; Kim JE; Moon SK; Kim SJ; Baek JH; Kim SH; Kim SH; Lee JY; Han JK; Choi BI
Radiology; 2011 May; 259(2):442-52. PubMed ID: 21406627
[TBL] [Abstract][Full Text] [Related]
4. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
5. Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases.
Seo HJ; Kim MJ; Lee JD; Chung WS; Kim YE
Invest Radiol; 2011 Sep; 46(9):548-55. PubMed ID: 21577131
[TBL] [Abstract][Full Text] [Related]
6. Contrast-enhanced 18F-FDG PET/CT: 1-stop-shop imaging for assessing the resectability of pancreatic cancer.
Strobel K; Heinrich S; Bhure U; Soyka J; Veit-Haibach P; Pestalozzi BC; Clavien PA; Hany TF
J Nucl Med; 2008 Sep; 49(9):1408-13. PubMed ID: 18703604
[TBL] [Abstract][Full Text] [Related]
7. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
[TBL] [Abstract][Full Text] [Related]
8. Non-small cell lung cancer staging: efficacy comparison of integrated PET/CT versus 3.0-T whole-body MR imaging.
Yi CA; Shin KM; Lee KS; Kim BT; Kim H; Kwon OJ; Choi JY; Chung MJ
Radiology; 2008 Aug; 248(2):632-42. PubMed ID: 18552311
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer: sextant localization with MR imaging, MR spectroscopy, and 11C-choline PET/CT.
Testa C; Schiavina R; Lodi R; Salizzoni E; Corti B; Farsad M; Kurhanewicz J; Manferrari F; Brunocilla E; Tonon C; Monetti N; Castellucci P; Fanti S; Coe M; Grigioni WF; Martorana G; Canini R; Barbiroli B
Radiology; 2007 Sep; 244(3):797-806. PubMed ID: 17652190
[TBL] [Abstract][Full Text] [Related]
10. Preoperative assessment of pancreatic tumors using magnetic resonance imaging, endoscopic ultrasonography, positron emission tomography and laparoscopy.
Borbath I; Van Beers BE; Lonneux M; Schoonbroodt D; Geubel A; Gigot JF; Deprez PH
Pancreatology; 2005; 5(6):553-61. PubMed ID: 16113592
[TBL] [Abstract][Full Text] [Related]
11. Non-small cell lung cancer: whole-body MR examination for M-stage assessment--utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT.
Ohno Y; Koyama H; Onishi Y; Takenaka D; Nogami M; Yoshikawa T; Matsumoto S; Kotani Y; Sugimura K
Radiology; 2008 Aug; 248(2):643-54. PubMed ID: 18539889
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic adenocarcinoma: variability of diffusion-weighted MR imaging findings.
Fukukura Y; Takumi K; Kamimura K; Shindo T; Kumagae Y; Tateyama A; Nakajo M
Radiology; 2012 Jun; 263(3):732-40. PubMed ID: 22623694
[TBL] [Abstract][Full Text] [Related]
13. Poorly enhanced areas of pancreatic adenocarcinomas on late-phase dynamic computed tomography: comparison with pathological findings.
Hattori Y; Gabata T; Zen Y; Mochizuki K; Kitagawa H; Matsui O
Pancreas; 2010 Nov; 39(8):1263-70. PubMed ID: 20467344
[TBL] [Abstract][Full Text] [Related]
14. Dynamic contrast-enhanced MR imaging and dual-phase helical CT in the preoperative assessment of suspected pancreatic cancer: a comparative study with receiver operating characteristic analysis.
Sheridan MB; Ward J; Guthrie JA; Spencer JA; Craven CM; Wilson D; Guillou PJ; Robinson PJ
AJR Am J Roentgenol; 1999 Sep; 173(3):583-90. PubMed ID: 10470884
[TBL] [Abstract][Full Text] [Related]
15. Gadobenate dimeglumine-enhanced 3.0-T MR imaging versus multiphasic 64-detector row CT: prospective evaluation in patients suspected of having pancreatic cancer.
Koelblinger C; Ba-Ssalamah A; Goetzinger P; Puchner S; Weber M; Sahora K; Scharitzer M; Plank C; Schima W
Radiology; 2011 Jun; 259(3):757-66. PubMed ID: 21436084
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic adenocarcinoma: CT versus MR imaging in the evaluation of resectability--report of the Radiology Diagnostic Oncology Group.
Megibow AJ; Zhou XH; Rotterdam H; Francis IR; Zerhouni EA; Balfe DM; Weinreb JC; Aisen A; Kuhlman J; Heiken JP
Radiology; 1995 May; 195(2):327-32. PubMed ID: 7724748
[TBL] [Abstract][Full Text] [Related]
17. Contrast-enhanced CT and diffusion-weighted MR imaging: performance as a prognostic factor in patients with pancreatic ductal adenocarcinoma.
Fukukura Y; Takumi K; Higashi M; Shinchi H; Kamimura K; Yoneyama T; Tateyama A
Eur J Radiol; 2014 Apr; 83(4):612-9. PubMed ID: 24418286
[TBL] [Abstract][Full Text] [Related]
18. Isoattenuating insulinomas at biphasic contrast-enhanced CT: frequency, clinicopathologic features and perfusion characteristics.
Zhu L; Xue HD; Sun H; Wang X; He YL; Jin ZY; Zhao YP
Eur Radiol; 2016 Oct; 26(10):3697-705. PubMed ID: 26815370
[TBL] [Abstract][Full Text] [Related]
19. Distinguishing tumefactive demyelinating lesions from glioma or central nervous system lymphoma: added value of unenhanced CT compared with conventional contrast-enhanced MR imaging.
Kim DS; Na DG; Kim KH; Kim JH; Kim E; Yun BL; Chang KH
Radiology; 2009 May; 251(2):467-75. PubMed ID: 19261924
[TBL] [Abstract][Full Text] [Related]
20. Intraductal papillary mucinous neoplasm of pancreas: multi-detector row CT with 2D curved reformations--correlation with MRCP.
Sahani DV; Kadavigere R; Blake M; Fernandez-Del Castillo C; Lauwers GY; Hahn PF
Radiology; 2006 Feb; 238(2):560-9. PubMed ID: 16436817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
